| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Jean-François Geschwind | |
| Lin Mu | |||
| Julius Chapiro | |||
| Jeremiah Stringam | |||
| P2860 | cites work | Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma | Q24186130 |
| Irreversible electroporation: state of the art | Q26746226 | ||
| C-arm cone beam CT for hepatic tumor ablation under real-time 3D imaging | Q84090034 | ||
| Three-dimensional C-arm cone-beam CT: applications in the interventional suite | Q84135421 | ||
| Radiofrequency ablation of colorectal liver metastases induces an inflammatory response in distant hepatic metastases but not in local accelerated outgrowth | Q84206857 | ||
| EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization | Q84441129 | ||
| Dose and image quality of cone-beam computed tomography as compared with conventional multislice computed tomography in abdominal imaging | Q87930034 | ||
| Advances in local ablation of malignant liver lesions | Q26751403 | ||
| Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma | Q26753089 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 | ||
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| Sorafenib in advanced hepatocellular carcinoma | Q27861075 | ||
| How I do it: Cone-beam CT during transarterial chemoembolization for liver cancer | Q28087066 | ||
| Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma | Q28247867 | ||
| Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial | Q29547903 | ||
| Hepatocellular carcinoma | Q29616359 | ||
| Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver | Q29616866 | ||
| Prognosis of hepatocellular carcinoma: the BCLC staging classification | Q29619984 | ||
| Reporting results of cancer treatment | Q29620070 | ||
| New data supporting modified RECIST (mRECIST) for Hepatocellular Carcinoma | Q30587001 | ||
| Ultrafast cone-beam computed tomography imaging and postprocessing data during image-guided therapeutic practice | Q30841508 | ||
| Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data | Q31036824 | ||
| Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma | Q33399560 | ||
| Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment? | Q34065128 | ||
| Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10. | Q34205626 | ||
| The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma | Q34312854 | ||
| Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study | Q34551964 | ||
| Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis | Q34680081 | ||
| Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma | Q34696783 | ||
| The pilot experience upon surgical ablation of large liver tumor by microwave system with tissue permittivity feedback control mechanism | Q34761934 | ||
| Assessment of liver ablation using cone beam computed tomography | Q34932543 | ||
| Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma | Q35085486 | ||
| Multicenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinoma | Q35116226 | ||
| Pattern of retained contrast on immediate postprocedure computed tomography (CT) after particle embolization of liver tumors predicts subsequent treatment response. | Q35383390 | ||
| Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma. | Q35668720 | ||
| Transcatheter intraarterial therapies: rationale and overview | Q36104314 | ||
| A new angiographic imaging platform reduces radiation exposure for patients with liver cancer treated with transarterial chemoembolization | Q36128106 | ||
| Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma | Q36296750 | ||
| A Novel Inherently Radiopaque Bead for Transarterial Embolization to Treat Liver Cancer - A Pre-clinical Study | Q36372328 | ||
| DC BeadM1™: towards an optimal transcatheter hepatic tumour therapy | Q36378569 | ||
| Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach | Q36416250 | ||
| Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma? | Q36573406 | ||
| Quantitative and volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembo | Q36630342 | ||
| Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma. | Q36673829 | ||
| Radiofrequency ablation and chemoembolization for hepatocellular carcinoma | Q37129523 | ||
| Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone | Q37138263 | ||
| Exploring intra- and inter-reader variability in uni-dimensional, bi-dimensional, and volumetric measurements of solid tumors on CT scans reconstructed at different slice intervals | Q37295117 | ||
| Effect of preoperative transcatheter arterial chemoembolization on angiogenesis of hepatocellular carcinoma cells | Q37362894 | ||
| Modified RECIST (mRECIST) assessment for hepatocellular carcinoma | Q37696396 | ||
| Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization? | Q37808643 | ||
| Hepatic resection vs minimally invasive radiofrequency ablation for the treatment of colorectal liver metastases: a Markov analysis | Q37979797 | ||
| Sorafenib alone versus sorafenib combined with transarterial chemoembolization for advanced-stage hepatocellular carcinoma: results of propensity score analyses. | Q38122306 | ||
| Cone Beam Computed Tomography (CBCT) in the Field of Interventional Oncology of the Liver | Q38547878 | ||
| Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial. | Q38711169 | ||
| In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization? | Q38984450 | ||
| Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study | Q39548624 | ||
| Usefulness of cone-beam volume CT with flat panel detectors in conjunction with catheter angiography for transcatheter arterial embolization | Q39824361 | ||
| Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study | Q39979280 | ||
| Imaging guidance with C-arm CT: prospective evaluation of its impact on patient radiation exposure during transhepatic arterial chemoembolization | Q39996513 | ||
| TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON. | Q40129689 | ||
| High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies | Q40227356 | ||
| First Human Experience with Directly Image-able Iodinated Embolization Microbeads | Q40375846 | ||
| Percutaneous Ablation of Hepatic Tumors Using Irreversible Electroporation: A Prospective Safety and Midterm Efficacy Study in 34 Patients. | Q40883089 | ||
| Evaluation of 70-150-μm doxorubicin-eluting beads for transcatheter arterial chemoembolization in the rabbit liver VX2 tumour model. | Q41641204 | ||
| Transarterial chemoembolization for hepatocellular carcinoma with a new generation of beads: clinical-radiological outcomes and safety profile. | Q42216297 | ||
| Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma | Q44637283 | ||
| Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. | Q44885846 | ||
| Irreversible Electroporation versus Radiofrequency Ablation: A Comparison of Local and Systemic Effects in a Small-Animal Model | Q45856454 | ||
| Oncogenesis: An "Off-Target" Effect of Radiofrequency Ablation | Q45874400 | ||
| Radiofrequency Ablation: Inflammatory Changes in the Periablative Zone Can Induce Global Organ Effects, including Liver Regeneration | Q45874404 | ||
| Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patients. | Q45913015 | ||
| CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size | Q47222111 | ||
| The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trial | Q48238287 | ||
| Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy. | Q50890846 | ||
| Flat-panel cone-beam CT-guided radiofrequency ablation of very small (≤ 1.5 cm) liver tumors: technical note on a preliminary experience. | Q51102892 | ||
| Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response. | Q51269627 | ||
| Electrochemical Effects after Transarterial Chemoembolization in Combination with Percutaneous Irreversible Electroporation: Observations in an Acute Porcine Liver Model. | Q52983472 | ||
| Interobserver and intraobserver variability in the response evaluation of cancer therapy according to RECIST and WHO-criteria. | Q53066813 | ||
| Oncogenesis: An "Off-Target" Effect of Radiofrequency Ablation. | Q53216210 | ||
| Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC. | Q53525194 | ||
| Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study | Q57168139 | ||
| Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial | Q57762740 | ||
| Increased Expression of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization | Q58257793 | ||
| Comparing the detectability of hepatocellular carcinoma by C-arm dual-phase cone-beam computed tomography during hepatic arteriography with conventional contrast-enhanced magnetic resonance imaging | Q83426771 | ||
| Ablation margin assessment of liver tumors with intravenous contrast-enhanced C-arm computed tomography | Q83788986 | ||
| P433 | issue | 6 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 365-372 | |
| P577 | publication date | 2016-11-01 | |
| P1433 | published in | The Cancer Journal | Q2589130 |
| P1476 | title | Interventional Oncology in Hepatocellular Carcinoma: Progress Through Innovation | |
| P478 | volume | 22 |
| Q38904263 | New concepts in embolotherapy of HCC. | cites work | P2860 |
Search more.